Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014

Influenza and other Respiratory Viruses

Volumn 9, Issue 4, 2015, Pages 209-215

  Mcanerney, Johanna M ^a   Treurnicht, Florette ^a   Walaza, Sibongile ^a,b   Cohen, Adam L ^c,d   Tempia, Stefano ^a,c,d   Mtshali, Senzo ^a   Buys, Amelia ^a   Blumberg, Lucille ^a   Cohen, Cheryl ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Centers for Disease Control and Prevention South Africa   (South Africa)

Author keywords

Effectiveness; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; OUTPATIENT CARE; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS DETECTION; VIRUS STRAIN; ADOLESCENT; IMMUNOLOGY; INFLUENZA, HUMAN; OUTPATIENT; SEASON; SENTINEL SURVEILLANCE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTPATIENTS; SEASONS; SENTINEL SURVEILLANCE; SOUTH AFRICA; YOUNG ADULT;

EID: 84930797216     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12314     Document Type: Article

References (22)

1. Walaza S. Recommendations pertaining to the use of viral vaccines: influenza 2014. S Afr Med J 2014; 104:166-167.
2. Flannery B, Thaker SN, Clippard J et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. MMWR Morb Mortal Wkly Rep 2014; 63:137-142.
3. Skowronski D, Chambers C, Sabaiduc S et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada's sentinel surveillance network, January 2014. Euro Surveill 2014; 19: pii:20690.
4. Turner N, Pierse N, Huang Q et al. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. Euro Surveill 2014; 19: pii: 20934.
5. Castilla J, Martinez-Baz I, Navascues A et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill 2014; 19: pii:20700.
6. McAnerney J, Walaza S, Cohen AL et al. Effectiveness and knowledge, attitudes and practises of seasonal influenza vaccine in primary health care settings in South Africa, 2010-2013. Influenza Other Respir Viruses 2015; 9:143-150. doi:10.1111/irv.12305.
7. McAnerney JM, Cohen C, Moyes J et al. Twenty-five years of outpatient influenza surveillance in South Africa, 1984-2008. J Infect Dis 2012; 206(Suppl 1):S153-S158.
8. Pretorius M, Madhi SM, Cohen C et al. Respiratory viral co-infections identified by a 10-plex realtime polymerase chain reaction assay in patients hospitalized with Severe Acute Respiratory Illness-South Africa. J Infect Dis 2012; 206(Suppl 1):S159-S165.
9. Selvaraju SB, Selvarangan R. Evaluation of three influenza A and B real-time reverse transcription-PCR assays and a new 2009 H1N1 assay for detection of influenza viruses. J Clin Microbiol 2010; 48:3870-3875.
10. Savulescu C, Jimenez-Jorge S, Delgado-Sanz C et al. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. Vaccine 2014; 32:4404-4411.
11. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599.
12. Zhang M, Gaschen B, Blay W et al. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004; 14:1229-1246.
13. Organization WH. Recommended composition of influenza virus vaccines for use in the 2014-15 northern hemisphere influenza season. World Health Organization [Internet]. 2014 Available at www.who.int/influenza/vaccines/virus/recommendations/2014_15.../en/ (Accessed 15 December 2014).
14. Zanini F, Neher RA. Quantifying selection against synonymous mutations in HIV-1 env evolution. J Virol 2013; 87:11843-11850.
15. Gog JR, Afonso Edos S, Dalton RM et al. Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res 2007; 35:1897-1907.
16. Wolf YI, Viboud C, Holmes EC, Koonin EV, Lipman DJ. Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct 2006; 1:34.
17. Pebody RG, Warburton F, Ellis J et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill 2015; 20:21025.
18. Broberg E, Snacken R, Aldhoch C et al. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill 2015; 20:pii: 21023.
19. Flannery B, Clippard J, Zimmerman RK et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep 2015; 64:10-15.
20. McNeil S, Andrew M, Ye L et al. Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015. Euro Surveill 2015; 20:21024.
21. Skowronski D, Chambers C, Sabaiduc S et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada's sentinel surveillance network, January 2014. Euro Surveill 2014; 19:pii: 20690.
22. Haveri A, Ikonen N, Julkunen I et al. Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine. Euro Surveill 2015; 20:21028.